Annovis Bio Investor Relations Material
Latest events
Status Update
Annovis Bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Annovis Bio Inc
Access all reports
Annovis Bio Inc. is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and other central nervous system disorders. The company specializes in small molecule therapies designed to reduce neurotoxic proteins and improve brain function. The company is headquartered in Berwyn, Pennsylvania, and its shares are listed on the NASDAQ.
)
)
)